Severance Hospital, Yonsei University Health System ( Site 5903) — Seoul

Public research footprint of Severance Hospital, Yonsei University Health System ( Site 5903), compiled from the ClinicalTrials.gov public registry.

1,060

Registered studies

484

Active

253

Recruiting now

423

Completed

112

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · HR Low-Positive/HER2-Negative Breast Neoplasms · Relapsed or Refractory Multiple Myeloma

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05583617 — A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Severance Hospital, Yonsei University Health System ( Site 5903)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.